Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 14/20 | 0.53 |
| ▸ | DYRK1A | Q13627 | 14/20 | 0.53 |
| ▸ | WNT1 | P04628 | 9/20 | 0.53 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.36 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23048575 | 0.81 | HCAR3 (0.35) | GSK3BDYRK1AWNT1ABL1 | |
| SCHEMBL23740895 | 0.80 | GSK3B (0.57) | GSK3BDYRK1AWNT1 | |
| SCHEMBL24219182 | 0.78 | DYRK1A (0.51) | GSK3BDYRK1AWNT1ABL1 | |
| SCHEMBL23740840 | 0.78 | GSK3B (0.59) | GSK3BDYRK1AWNT1 | |
| SCHEMBL23741009 | 0.77 | GSK3B (0.60) | GSK3BDYRK1AWNT1 | |
| SCHEMBL24218957 | 0.76 | GSK3B (0.60) | GSK3BDYRK1AWNT1 | |
| SCHEMBL19546597 | 0.75 | DYRK1A (0.42) | GSK3BDYRK1AWNT1 | |
| SCHEMBL24218960 | 0.75 | USP30 (0.32) | GSK3BDYRK1AWNT1 | |
| SCHEMBL18900168 | 0.75 | ABL1 (0.57) | ABL1 | |
| SCHEMBL23916218 | 0.74 | DYRK1A (0.39) | GSK3BDYRK1AWNT1ABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3448838-B1 | ISOQUINOLIN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF | BIOSPLICE THERAPEUTICS INC (US) | 2021-08-11 | — | — | EP | disclosed |